P
UTMD icon

&Partners’s Utah Medical Products UTMD Stock Holding History

&Partners’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Buy
5,003
+1,207
+32% +$76K ﹤0.01% 1972
2025
Q4 		$212K Buy
3,796
+396
+12% +$23K ﹤0.01% 2112
2025
Q3 		$214K Buy
+3,400
New +$201K ﹤0.01% 1934

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

&Partners's UTMD Position: Q1 2026 in Review

&Partners increased its Utah Medical Products (UTMD) stake by 32% in Q1 2026, buying an estimated $76K and bringing the position to 5,003 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #1972.

&Partners first reported a position in UTMD in Q3 2025 and has held it in 3 quarters since. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • &Partners held 5,003 shares of Utah Medical Products worth $310K as of Q1 2026.
  • &Partners bought 1,207 Utah Medical Products shares in Q1 2026, an estimated $76K.
  • Utah Medical Products made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1972 holding.
  • &Partners first reported a position in Utah Medical Products in Q3 2025 and has held it in 3 quarters since.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.